help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on February 5, 2004, doi:10.1165/rcmb.2003-0380OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0380OCv1
31/1/92    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, T. S.
Right arrow Articles by Wight, T. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, T. S.
Right arrow Articles by Wight, T. N.
American Journal of Respiratory Cell and Molecular Biology. Vol. 31, pp. 92-99, 2004
© 2004 American Thoracic Society
DOI: 10.1165/rcmb.2003-0380OC


Original Article

Pro- and Anti-Inflammatory Factors Cooperate to Control Hyaluronan Synthesis in Lung Fibroblasts

Thomas S. Wilkinson, Susan Potter-Perigo, Christina Tsoi, Leonard C. Altman and Thomas N. Wight

Department of Vascular Biology, Hope Heart Institute, Seattle; and Department of Medicine, Division of Allergy and Infectious Disease, and Department of Pathology, University of Washington, Seattle, Washington

Address correspondence to: T. N. Wight, Ph.D., Department of Vascular Biology, The Hope Heart Institute, 1124 Columbia Street, Seattle, WA 98104-2046. E-mail: twight{at}hopeheart.org

Hyaluronan (HA) is an important constituent of the extracellular matrix and accumulates during inflammatory lung diseases like asthma. Little is known about the factors that regulate HA synthesis by lung cells. Accordingly, we investigated the effect of T-helper 1 (TH1) and 2 (TH2) cytokines and the anti-inflammatory agents fluticasone and salmeterol on HA synthesis in human lung fibroblasts. Interleukin-1ß (IL-1ß) and tumor necrosis factor (TNF)-{alpha} were the most potent stimulators of HA synthesis and when combined, caused synergistic increases in HA accumulation. Time-course analysis of HA accumulation and [3H]-glucosamine incorporation into HA demonstrated continued synthesis over the 24 h of stimulation. Peak synthesis at 6–12 h coincided with an increased proportion of high molecular weight HA. Reverse transcriptase polymerase chain reaction (RT-PCR) revealed that IL-1ß and TNF-{alpha} induced HA synthase-2 messenger RNA (mRNA) 3 h following stimulation and remained elevated throughout the 24-h stimulation period. Fluticasone inhibited IL-1ß and TNF-{alpha} induced HA synthesis (44.5%) whereas salmeterol had no effect. When combined, fluticasone and salmeterol inhibited HA synthesis to a greater extent (85.2%). Further, fluticasone attenuated IL-1ß and TNF-{alpha} stimulated hyaluronan synthase-2 messenger RNA (mRNA), and the addition of salmeterol cooperatively enhanced this inhibition. These results indicate that enhanced synthesis of HA by the proinflammatory cytokines IL-1ß and TNF-{alpha} can be abrogated by specific corticosteroid and ß2 blocker combinations shown to be effective in the treatment of asthma.

Abbreviations: biotinylated proteoglycan, bPG • bovine serum albumin, BSA • complimentary DNA, cDNA • enzyme-linked immunosorbent assay, ELISA • extracellular matrix, ECM • ethylenediaminetetraacetic acid, EDTA • fetal bovine serum, FBS • glyceraldehyde-3-phosphate dehydrogenase, GAPDH • high molecular weight, HMW • hyaluronan, HA • hyaluronan synthase, HAS • Interferon, IFN • interleukin, IL • messenger RNA, mRNA • nuclear factor {kappa}B, NF-{kappa}B • reverse transcriptase polymerase chain reaction, RT-PCR • T-helper type 1, TH1 • T-helper type 2, TH2 • tumor necrosis factor {alpha}, TNF-{alpha}




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. W. Sakr, S. Potter-Perigo, M. G. Kinsella, P. Y. Johnson, K. R. Braun, Y. Goueffic, M. E. Rosenfeld, and T. N. Wight
Hyaluronan Accumulation Is Elevated in Cultures of Low Density Lipoprotein Receptor-deficient Cells and Is Altered by Manipulation of Cell Cholesterol Content
J. Biol. Chem., December 26, 2008; 283(52): 36195 - 36204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kawana, H. Karaki, M. Higashi, M. Miyazaki, F. Hilberg, M. Kitagawa, and K. Harigaya
CD44 Suppresses TLR-Mediated Inflammation
J. Immunol., March 15, 2008; 180(6): 4235 - 4245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Kastner, G. J. Thomas, R. H. Jenkins, M. Davies, and R. Steadman
Hyaluronan Induces the Selective Accumulation of Matrix- and Cell-Associated Proteoglycans by Mesangial Cells
Am. J. Pathol., December 1, 2007; 171(6): 1811 - 1821.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Y. Han, S. Subramanian, C. K. Chan, M. Omer, T. Chiba, T. N. Wight, and A. Chait
Adipocyte-Derived Serum Amyloid A3 and Hyaluronan Play a Role in Monocyte Recruitment and Adhesion
Diabetes, September 1, 2007; 56(9): 2260 - 2273.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Guo, D. Kanter, M. L. Funderburgh, M. M. Mann, Y. Du, and J. L. Funderburgh
A Rapid Transient Increase in Hyaluronan Synthase-2 mRNA Initiates Secretion of Hyaluronan by Corneal Keratocytes in Response to Transforming Growth Factor beta
J. Biol. Chem., April 27, 2007; 282(17): 12475 - 12483.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Monslow, J. D. Williams, D. J. Fraser, D. R. Michael, P. Foka, A. P. Kift-Morgan, D. D. Luo, C. A. Fielding, K. J. Craig, N. Topley, et al.
Sp1 and Sp3 Mediate Constitutive Transcription of the Human Hyaluronan Synthase 2 Gene
J. Biol. Chem., June 30, 2006; 281(26): 18043 - 18050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Rubio-Gayosso, S. H. Platts, and B. R. Duling
Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. Todorova, E. Gurcan, A. Miller-Larsson, and G. Westergren-Thorsson
Lung Fibroblast Proteoglycan Production Induced by Serum Is Inhibited by Budesonide and Formoterol
Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 92 - 100.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
C. W. Frevert and P. L. Sannes
Matrix proteoglycans as effector molecules for epithelial cell function
Eur. Respir. Rev., December 1, 2005; 14(97): 137 - 144.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Baouz, J. Giron-Michel, B. Azzarone, M. Giuliani, F. Cagnoni, S. Olsson, R. Testi, G. Gabbiani, and G. W. Canonica
Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of {alpha}-SMA and NF-{kappa}B
Int. Immunol., November 1, 2005; 17(11): 1473 - 1481.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2004 American Thoracic Society.
  2009 ATS Conference